GS
COCHW icon

GTS Securities’s Envoy Medical Warrant COCHW Stock Holding History

GTS Securities’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37,044
Closed -$741 – 3921
2023
Q4 		$741 Buy
+37,044
New +$1K ﹤0.01% 3965
2023
Q3 		– Sell
-39,526
Closed -$1.66K – 3933
2023
Q2 		$1.66K Buy
+39,526
New +$1.99K ﹤0.01% 1176

Other funds holding COCHW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

GTS Securities's COCHW Position: Q1 2024 in Review

GTS Securities sold out of Envoy Medical Warrant (COCHW) in Q1 2024, closing a stake of 37,044 shares — an estimated $741 sold.

GTS Securities first reported a position in COCHW in Q2 2023 and held it in 2 quarters. The position peaked at $1.66K in Q2 2023. 47 funds tracked by Wall St. Rank hold COCHW as of Q1 2024.

  • GTS Securities reported no remaining Envoy Medical Warrant position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 37,044 Envoy Medical Warrant shares in Q1 2024, an estimated $741.
  • GTS Securities first reported a position in Envoy Medical Warrant in Q2 2023 and held it in 2 quarters.
  • GTS Securities's Envoy Medical Warrant position peaked at $1.66K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.